×
Demant Cash on Hand 2012-2024 | WILYY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Demant cash on hand for the quarter ending December 31, 2024 was
$0.161B
, a
4.7% decline
year-over-year.
Demant cash on hand for 2024 was
$0.161B
, a
0% decline
from 2024.
Demant cash on hand for 2024 was
$0.161B
, a
2.42% decline
from 2023.
Demant cash on hand for 2023 was
$0.165B
, a
0% decline
from 2023.
View More
Demant Cash on Hand 2012-2024 | WILYY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Demant cash on hand for 2024 was
$0.161B
, a
0% decline
from 2024.
Demant cash on hand for 2024 was
$0.161B
, a
2.42% decline
from 2023.
Demant cash on hand for 2023 was
$0.165B
, a
0% decline
from 2023.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$229.2B
Boston Scientific (BSX)
$155.9B
Stryker (SYK)
$148.3B
EssilorLuxottica (ESLOY)
$140.1B
Medtronic (MDT)
$111.6B
Lonza Group Ag (LZAGY)
$46.2B
Haleon (HLN)
$45.2B
GE HealthCare Technologies (GEHC)
$42.3B
Agilent Technologies (A)
$39.1B
ResMed (RMD)
$34.4B
Terumo (TRUMY)
$26.6B
Koninklijke Philips (PHG)
$23.5B
Zimmer Biomet Holdings (ZBH)
$20.6B
Insulet (PODD)
$19.9B
Baxter (BAX)
$15.7B
Sunny Optical Technology (SNPTF)
$11.3B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.9B
Bio-Rad Laboratories (BIO)
$7.9B
Lantheus Holdings (LNTH)
$5.7B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.4B
Haemonetics (HAE)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B
LeMaitre Vascular (LMAT)
$2.3B
Neogen (NEOG)
$2.2B